Discgenics honored by goldman sachs for entrepreneurship

Salt lake city, oct. 18, 2021 /prnewswire/ --  discgenics, inc., a clinical stage biopharmaceutical company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced that goldman sachs (nyse:gs) recognized discgenics chairman and ceo flagg flanagan as one of the 100 most intriguing entrepreneurs of 2021 at its builders + innovators summit in healdsburg, california. goldman sachs selected mr.
GS Ratings Summary
GS Quant Ranking